Internal Medicine, Pulmonary Disease · Dallas, TX
NPI
1376761536
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5323 Harry Hines Blvd
Dallas, TX, 75390
Phone (214) 648-2546
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,727
98 services
Medicare patients, 2024
45
Average age 61
Drug cost, 2024
$2.4M
387 prescriptions
Company payments, 2025
$27K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raksha Jain was code 94010 (pulmonary function testing), 28 times for 15 patients. In total Raksha Jain billed 98 services in 12 codes, and Medicare paid $7,727.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94010 Pulmonary Function Testing | Office | 28 | 15 | $18.38 | $515 |
| 99233 Hospital E&M - Subsequent | Facility | 23 | 15 | $85.12 | $1,958 |
| 99291 Critical Care E&M | Facility | 13 | 12 | $164.46 | $2,138 |
By year: 2022 $11K for 142 services; 2023 $12K for 159 services; 2024 $7,727 for 98 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raksha Jain prescribed most often to Medicare patients was Trikafta (Elexacaftor/Tezacaftor/Ivacaft), with 69 prescriptions and refills. In total Raksha Jain wrote 387 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 69 | 71 | 14 | $1.8M |
| Montelukast Sodium Generic | 29 | 43 | Under 11 | $129 |
| Zenpep Lipase/Protease/Amylase | 29 | 37 | Under 11 | $195K |
| Fluticasone Propionate Generic | 22 | 39 | Under 11 | $208 |
| Cayston Aztreonam Lysine | 22 | 25 | Under 11 | $262K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 21 | 25 | Under 11 | $444 |
| Ursodiol Generic | 15 | 17 | Under 11 | $1,408 |
| Azithromycin Generic | 14 | 14 | Under 11 | $163 |
| Ventolin Hfa Albuterol Sulfate | 13 | 13 | Under 11 | $694 |
| Spiriva Respimat Tiotropium Bromide | 12 | 14 | Under 11 | $7,155 |
| Prednisone Generic | 11 | 11 | Under 11 | $14.57 |
Brand drugs: 218 claims; generic drugs: 169 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raksha Jain $27K ($27K in general payments such as food, travel and fees) from 4 companies. The largest payer was Boehringer Ingelheim International GmbH with $14K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.